NCT03761914 2024-11-19
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sellas Life Sciences Group
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Small Cell Lung Carcinoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all